The congress has been postponed. We will be announcing further information soon.

The International Scientific and Organising Committee is working to create a programme that represents the best European and global epileptology.

The programme will cover all aspects of epileptology, but four main themes have been selected, representing Adult Epileptology, Basic Science, Paediatric Epileptology and Pharmacology.

Sessions will include the Chairs’ Symposium, Special Symposia, Teaching Courses and Sessions, Platform Sessions, ECE Forums, the Symposium of Excellence in Epileptology, among others.

Click on the image below to view the overview of the programme schedule.

Please check back here for updates as the ISOC develops the programme: ECE2020 Programme Overview.

Chairs’ Symposium: Precision medicine for patients with epilepsy – are we there yet?

Co-chairs: Eugen Trinka (Austria) & Margitta Seeck (Switzerland)

  • How genetic findings impact patients’ treatment and prognosis – Sarah Weckhuysen (Belgium)
  • New imaging tools will advance patients’ diagnosis and treatment to the next level – Serge Vulliemoz (Switzerland)
  • New avenues in drug development will have an impact on patients’ life – Wolfgang Löscher (Germany)
  • What is needed to bring advances in diagnosis and treatment to the population? – The global implementation gap – Samuel Wiebe (Canada)


Neurodegeneration and epilepsy

  • Neurodegenerative disorders and seizures – the epidemiological view – Ettore Beghi (Italy)
  • The ABT of neurodegeneration: alpha synuclein, beta amyloid, and tau protein and their role in epileptogenesis – Katja Kobow (Germany)
  • Diagnosis – neuroimaging, CSF, EEG – Giovani Frisoni (Italy)
  • Therapeutic challenges of treating patients with epilepsy and neurodegenerative disorders – Stephan Rüegg (Switzerland)
  • The birth of hyperexcitability in Alzheimer’s Disease – Jeffrey Noebels (USA)


Novel approaches to drug discovery

  • Why we need novel approaches – Heidrun Potschka (Germany)
  • Novel models of paediatric epilepsies – Stéphane Auvin (France)
  • Zebra fish as tools for personalised medicine – Peter de Witte (Belgium)
  • Use of gene networks and induced pluripotent stem cells in drug discovery – tbc


Is it possible to predict outcome in childhood epilepsies?

  • The role of genetics: where to start for understanding outcome – Ingrid Scheffer (Australia)
  • Disease modifying treatments: is there an option? – Nicola Specchio (Italy)
  • Prediction of outcome after epilepsy surgery: what can we learn from the virtual brain? – Fabrice Bartolomei (France)
  • How EEG, MRI and neuroimaging of brain networks can help? – Torsten Baldeweg (United Kingdom)
  • The sooner, the better – Georgia Ramantani (Switzerland)


Future therapies for epilepsy

  • Update on new antiepileptic drugs in the pipeline – Meir Bialer (Israel)
  • Can we develop new therapies for therapy-resistant patients? – Matthew Walker (United Kingdom)
  • Impact of new regulatory guidelines on drug development approaches – Emilio Perucca (Italy)
  • Innovative treatments for orphan epilepsies, one at a time? – J Helen Cross (United Kingdom)
  • Update on new antiepileptic devices in the pipeline – Kristl Vonck (Belgium)


Epilepsy: a window to the brain and a public health imperative (WHO Session)

  • Introduction – Devora Kestel (WHO, Switzerland)
  • WHO-ILAE-IBE partnership in improving epilepsy care and research – Samuel Wiebe (Canada)
  • Prevention of epilepsy after brain lesions: an unmet need – Alla Guekht (Russian Federation)
  • Synergies in addressing the burden of epilepsy and other neurological disorders – Bill Carroll (Australia)
  • Epilepsy Alliance Europe: fostering research and innovations in epilepsy Eugen Trinka (Austria)
  • Panel Discussion

Epilepsy and inflammation – chicken or egg, or neither of them?

  • When inflammation causes epilepsy: the case for autoimmune encephalitis “chicken, egg or neither of them part I”? – Harald Prüss (Germany)
  • When epilepsy causes inflammation: “hen, egg or neither of them part II”? – Stephan Rüegg (Switzerland)
  • Rare or new causes of autoimmune encephalitis: “from hens and eggs…” – Marianna Spatola (Italy)
  • Immune histopathology of autoimmune encephalitis: “scrambled eggs on the microscope…” – Romana Höftberger (Austria)


ILAE-YES Session: The future of epileptology in 20 years: science or fiction?

  • Computational modelling of epilepsy and predicting neurosurgical outcomes – Luca de Palma (Italy)
  • Gauging seizure risk and tailoring epilepsy treatment using multiday cycles – Maxime Baud (Switzerland)
  • From genes to therapy – how genetic mutations can determine our treatment – Stephanie Schorge (United Kingdom)
  • Detecting seizures and preventing SUDEP – Sylvain Rheims (France)


Future diagnostics in epilepsy – are automated methods going to replace clinicians?

  • Artificial intelligence in digital pathology – long way to real intelligence – Samir Jabari (Germany)
  • Automated detection of focal cortical dysplasia using deep learning – Sophie Adler (United Kingdom)
  • Automated EEG processing in epilepsy – Pieter Van Mierlo (Belgium)
  • Computer-assisted planning of SEEG and laser trajectories: man vs. machine – Vejay Vakharia (United Kingdom)


The GABA wave 35 years on: the lessons from GABAergic drugs for future drug development

  • The GABA wave – a history of vigabatrin and CNS-active GABA derivatives in epilepsy – Simon Shorvon (United Kingdom)
  • How vigabatrin, progabide and tiagabine affected the development of new CNS-active GABA derivatives – Meir Bialer (Israel)
  • The current role of GABA derivatives in epilepsy treatment – Reetta Kälviäinen (Finland)
  • Can we develop better GABA Derivatives than the currently available commercially? – Wolfgang Löscher (Germany)


Genetic therapy for refractory epilepsy

  • Seizure suppression with neuropeptide gene therapy – Merab Kokaia (Sweden)
  • CRISPR gene therapy for epilepsy – Gaia Colasante (Italy)
  • Auto-regulatory gene therapy for epilepsy – Andreas Lieb (Austria)
  • RNA therapy for epilepsy – David Henshall (Ireland)


Electromagnetic source imaging in presurgical evaluation: get it into your clinical practice!

  • EEG source imaging of interictal epileptiform discharges – Margitta Seeck (Switzerland)
  • EEG source imaging of ictal activity – Sandor Beniczky (Denmark)
  • MEG source imaging – Hermann Stefan (Germany)
  • EEG connectivity in presurgical evaluation – Serge Vulliemoz (Switzerland)


Multi-scale recordings: new windows on epileptic networks

  • Simultaneous EEG-SEEG during electrical cortical stimulation – Andrei Barborica (Romania)
  • Can we detect mesial activity non-invasively? Insights from simultaneous MEG/EEG/SEEG recordings – Francesca Pizzo (France)
  • Microelectrode recordings reveal the organisation of ictal neuronal behaviour – Pierre Megevand (Switzerland)
  • A multiscale analysis of fast-ripples in epileptic patients: their relations to single neuron activity and interictal epileptic discharges – Jonathan Curot (France)


Predict and monitor epilepsy after the first epileptic seizure: new tools from EEG and imaging

  • Prediction of outcome based on clinical variables – Anthony Marson (United Kingdom)
  • First seizure and new-onset epilepsy: the Geneva experience – Margitta Seeck (Switzerland)
  • Diagnostic yield of advanced MRI imaging in a first seizure setting – Roland Wiest (Switzerland)
  • The present and future: are there EEG biomarkers for seizure recurrence? – Pieter Van Mierlo (Belgium)


Biology and treatments for CDKL5 Deficiency Disorder

  • Biology of CDKL5 deficiency – Vera Kalscheuer (Germany)
  • Preclinical treatments in development for CDD – Charlotte Kilstrup-Nielsen (Italy)
  • Clinical presentation of CDD – Nadia Bahi-Buisson (France)
  • Clinical treatments in development for CDD – J Helen Cross (United Kingdom)


Safety first – how to use registries for improved patient care

  • Population-based studies for diagnosis and predictions of risks – Jakob Christensen (Denmark)
  • The use of therapeutic drug monitoring and prescription databases to monitor safety at the patient and population levels – Cecilie Johannessen Landmark (Norway)
  • The use of a prescription registry for surveillance of adherence and success of treatment – Hajo Hamer (Germany)
  • Mortality and life expectancy in epilepsy – Claudia Granbichler (Austria)


The potential of transcranial magnetic stimulation in epilepsy care

  • State of the art of TMS in epilepsy – presentation of the EpiStim Consortium – Mark Richardson (United Kingdom) & Sanjay Sisodiya (United Kingdom)
  • TMS-EEG to track response to pharmacological treatment in epilepsy – Isabella Premoli (United Kingdom)
  • TMS-EEG as a tool in genotype-phenotype correlation – Simona Balestrini (United Kingdom)
  • TMS-EEG in the epilepsy monitoring unit – Robert Helling (Netherlands)


The role of (epi)genetics in epilepsy: new targeting strategies and implications for diagnosis and treatment

  • Critical role of DNA methylation and histone modification changes for the development and progression of epilepsy – Katja Kobow (Germany)
  • (Post)transcriptional profiling in human epilepsy – Albert Becker (Germany)
  • Small non-coding RNAs as novel therapeutic targets and biomarkers for epilepsy – Erwin van Vliet (Netherlands)
  • Circadian regulation of gene expression following acquired epileptic insults and seizures – Cristina Ruedell Reschke (Ireland)


Sodium channel epileptic encephalopathies: phenotypic heterogeneity and therapeutic options

  • SCN1A related phenotypes, novel neurobiological concepts and therapies – Andreas Brunklaus (United Kingdom)
  • Genetic and phenotypic heterogeneity and therapeutic implications in SCN2A-related disorders – Markus Wolff (Germany)
  • The phenotypic spectrum of SCN8A-related disorders and treatment options – Elena Gardella (Denmark)
  • Voltage-gated Na+ channels: electrophysiology, pathophysiology and therapeutic implications – Massimo Mantegazza (France)


Super-refractory Status Epilepticus – the way forward

  • How good are the conventional therapies? – Simon Shorvon (United Kingdom)
  • Tearing up the pharmacokinetic principles of epilepsy – Meir Bialer (Israel)
  • Novel approaches – Reetta Kälviäinen (Finland)
  • Why try immunological therapy? – Eugen Trinka (Austria)


Women and epilepsy – lifelong considerations

  • Epilepsy, hormones and the menstrual cycle – Gyri Veiby (Norway)
  • Epilepsy and new mothers – Torbjörn Tomson (Sweden)
  • Epilepsy and older women – Martin Brodie (Scotland)
  • Quality of life in women with epilepsy – Linda Stephen (United Kingdom)


Individualising antiepileptic drug treatment

  • Therapeutic drug monitoring – Jan Novy (Switzerland)
  • Treatment response prediction – Chantal Depondt (Belgium)
  • Inflammatory biomarkers for epilepsy – Annamaria Vezzani (Italy)
  • Prediction of drug side-effects – Norman Delanty (Ireland)


Antiepileptogenesis, the holy grail: how can we find and assess potential treatments?

  • Genomic approaches to drug repurposing – Nasir Mirza (United Kingdom)
  • Antiepileptogenesis in high risk patients following acute brain insults – Johan Zelano (Sweden)
  • Antiepileptogenesis in high risk patients following first seizure – Anthony Marson (United Kingdom)


Clinical neurophysiology for coma prognostication after cardiac arrest

  • Introduction from a neurointensive standpoint – Mauro Oddo (Switzerland)
  • EEG: prognostic value and status epilepticus detection – Sofia Backman (Sweden)
  • SSEP: pearls and pitfalls – Christoph Leithner (Germany)
  • Postanoxic SE management – Andrea Rossetti (Switzerland)


Seizure dynamics on the scale of years, days, hours and seconds

  • Seizure dynamics on the scale of years – Maxime Baud (Switzerland)
  • Seizure dynamics on the scale of days – Philippa Karoly (Australia)
  • Seizure dynamics on the scale of hours – Christophe Bernard (France)
  • Seizure dynamics on the scale of seconds – Kaspar Schindler (Switzerland)


Mapping brain function

  • An electrical atlas of the brain – Birgit Frauscher (Canada)
  • A road map of the brain – Olivier David (France)
  • A cognitive map of the brain – Tonio Ball (Germany)
  • How reliable is brain stimulation for brain mapping? – Agnès Trébuchon (France)


Pharmaco MRI in epilepsy

  • Antiepileptic drugs effects on cognitive networks as revealed by functional MRI – Lorenzo Caciagli (United Kingdom)
  • Antiepileptic drugs effects on epilepsy networks – Britta Wandschneider (United Kingdom)
  • Antiepileptic drugs and structural cortical/subcortical brain changes – Stefano Meletti (Italy)


What should child neurologists know when treating children with comorbidities?

  • Therapeutic approaches to children with mood and anxiety disorders – Sophie Bennett (United Kingdom)
  • Managing behavioural disorders in children with epilepsy and autism at the transition phase – Gudrun Gröppel (Austria)
  • ASM choice for children with a neuropsychiatric comorbidity – Kette Valente (Brazil)
  • The impact of epilepsy surgery in the presence of neuropsychiatric disorders – Elaine Wirrell (USA)


Dravet Syndrome beyond epilepsy

  • SUDEP and acute encephalopathy in Dravet Syndrome – Federico Vigevano (Italy)
  • Language – communication disorder – Rima Nabbout (France)
  • Behavioural aspects / issues – Eva Brilstra (Netherlands)
  • Orthopaedic and gait problems – Ann Hallemans (Belgium)
  • Sleep disorder Gaetano Cantalupo (Italy)


Neuropsychiatric challenges in epilepsy care

  • Treatment of psychiatric comorbidities in patients with epilepsy and intellectual disabilities: is there a role for the neurologist? – Michael Kerr (United Kingdom)
  • Pharmacotherapy in patients with epilepsy and psychosis – Bettina Schmitz (Germany)
  • The association of panic and hyperventilation with psychogenic non-epileptic seizures in patients with PNES – Markus Reuber (United Kingdom)
  • Delineating behavioural and cognitive phenotypes in juvenile myoclonic epilepsy: are we missing the forest for the trees? – Julia Höfler (Austria)


Diagnosing neuropsychiatric conditions in paediatric epilepsy

  • Depression and anxiety in children with epilepsy: key steps to the diagnosis – Colin Reilly (Sweden)
  • A neuropaediatric approach to autism – Stéphane Auvin (France)
  • The identification of ADHD in childhood and adolescence – Alexis Arzimanoglou (France)
  • The role of transition clinics in the identification and prevention of psychiatric comorbidities – Marco Mula (United Kingdom)


Optimising resection planning and clinical outcomes following epilepsy surgery

  • The importance of identifying white matter tracts in optimising resections in epilepsy surgery – Laura Tassi (Italy)
  • Imaging and navigating white matter tracts to optimise patient outcome – Vejay Vakharia (United Kingdom)
  • What neurophysiology of the white matter tracts can teach us about epilepsy and neurological function – Philippe Kahane  (France)
  • Techniques to improve extent of surgical resection and minimise morbidity – Karl Rössler (Germany)


Non- and minimal-invasive ablation: the future, the past and the present

  • The future: MR-guided-focused ultrasound: why are certain epileptogenic lesions are putative targets? – Karl Schaller (Switzerland)
  • Thermocoagulation – Laura Tassi (Italy)
  • The present I: MR-guided-laser-interstitial thermal therapy: in 10 years from single cases to larger series – Robert Gross (USA)
  • The present II: cases in Europe – how the overseas experiences influenced our perception – Friedrich Carl Schmitt (Germany)


Advances in understanding of focal cortical dysplasias and the mTOR pathway

  • The neurobiology of mTOR pathway – Paolo Curatolo (Italy)
  • Neuropathological spectrum of cortical malformations as basis for improved pathogenetic understanding – Albert Becker (Germany)
  • Brain somatic mTOR mutations in focal cortical dysplasias: relevance for clinical diagnosis – Stéphanie Baulac (France)
  • Electro-clinico-imaging phenotype of genetic focal cortical dysplasias – Fabienne Picard (Switzerland)


Update in hemispherotomy: chances, challenges and perspectives

  • Challenges and updates in hemispheric surgery – Martin Tisdal (United Kingdom)
  • Predicting long-term seizure outcomes – Georgia Ramantani (Switzerland)
  • Predicting long-term functional outcomes – Kees Braun (Netherlands)
  • Predicting long-term cognitive  outcomes – Christine Bulteau (France)


Cure for Epilepsy – What is the Future? – ILAE-Europe – EAN Symposium

  • Cure of Epilepsy – What are the unmet needs? – Elinor Ben-Menachem (Sweden)
  • Neuroinflammation in epilepsy: biomarkers and treatment targets – Teresa Ravizza (Italy)
  • Antisense Oligonucleotides in Epilepsy – José Serratosa (Spain)


Stroke and epilepsy:  unresolved issues of key noncommunicable diseases

  • Prevention of seizures in acute stroke: are we there yet? – Marian Galovic (Switzerland)
  • Reperfusion therapies and seizure development – is there an association? – Alla Guekht (Russian Federation)
  • Young and elderly stroke patients with epilepsy – Vincent Alvarez (Switzerland)
  • Seizures imitating strokes imitating seizures – Eugen Trinka (Austria)


Neurobiology Symposium:  The tales of tau in epilepsy, sleep and SUDEP

  • Targeting tau in epilepsy: lessons from animal models – Sandy Schultz (Australia)
  • Of sleep and death in epilepsy: the tales of tau – Jerrah Holth (USA)
  • Tau spreading and disease progression – tbc
  • Targeting tau in human epilepsy: why, when, how? – Matthias Koepp (United Kingdom)

Full-day Teaching Course: Neuroimaging in epilepsy – what the clinician should know

Chair: Paolo Federico (Canada)

  • Introduction to neuroimaging in epilepsy – Paolo Federico (Canada)
  • MRI physics, sequence names, and MRI epilepsy protocol – Stefan Rampp (Germany)
  • Common epileptic pathologies: temporal epilepsy – Angelo Labate (Italy)
  • Common epileptic pathologies: extratemporal lobe epilepsy – John Duncan (United Kingdom)
  • Hands-on session
  • MRI-negative epilepsy. What are the next steps? – John Duncan (United Kingdom)
  • Other neuroimaging modalities: PET, SPECT, etc. – Anna Elisabetta Vaudano (Italy)
  • fMRI (task-based) and EEG-fMRI  – Anna Elisabetta Vaudano (Italy)
  • Hands-on session
  • Group discussion/feedback


Half-day Teaching Course: Is this a seizure? If not, what is it?

Co-chairs: Alla Guekht (Russian Federation) & Nicola Specchio (Italy)

This session will address differential diagnosis: epileptic seizures vs. non-epileptic paroxysmal events. How to extract relevant clinical information from history and from video recordings.

  • Brief introduction to the topic and aims of the Course – Alla Guekht (Russian Federation) & Nicola Specchio (Italy)
  • The challenge of a correct diagnosis in infants and children – Nicola Specchio (Italy)
  • Hyperkinetic movements: what we learned after 20 years of clinical reports – Lino Nobili (Italy)
  • Psychiatric comorbidities in epilepsy: coexistence of both epileptic and non-epileptic events. How to deal with? – Alla Guekht (Russian Federation)
  • Loss of consciousness and insane automatisms – Markus Reuber (United Kingdom)


Half-day Teaching Course: Classify this!

Co-chairs: Ronit Pressler (United Kingdom) & Philippe Ryvlin (Switzerland)

This interactive session will use a case-based approach to teach classification of seizures and epilepsy.

  • Classification of seizure in adults – Philippe Ryvlin (Switzerland) & Matthew Walker (United Kingdom)
  • Classification of seizure and syndromes in neonates and children – Ronit Pressler (United Kingdom) & Christian Korff (Switzerland)


Half-day Teaching Course: Let´s read EEGs together!

Chair: Sándor Beniczky (Denmark)

In the first part, the following theoretical blocks will be addressed: how to localize an EEG abnormality, interictal patterns, ictal patterns, normal variants and artefacts. In the second part, the tutors will read representative EEG samples together with the students.Sándor Beniczky (Denmark)

  • Introduction – how to systematically read EEGs – Sándor Beniczky (Denmark)
  • Interictal and ictal patterns – Dana Craiu (Romania)
  • How to localize an EEG abnormality – Margitta Seeck (Switzerland)
  • Normal variants and artefacts – Michael Sperling (USA)
  • Interactive reading session


Half-day Teaching Course: Which ASM to start with? When to stop?

Chair: Cecilie Johannessen Landmark (Norway)

This session will address the choice of first ASM, and discuss the factors that are important for making this decision. In addition, the speakers will discuss the way the ASMs are introduced, when and how to stop them.

The learning objectives according to the ILAE EpiEd Task force Roadmap (Blümcke et al., 2019) will be specified.

  • Introduction and aims of the course related to the specified learning outcomes – Cecilie Johannessen Landmark (Norway)
  • Considerations for safe choices: drug interactions and teratogenicity – Sara Eyal (Israel)
  • When to start and which ASM? – Emilio Perucca (Italy)
  • When and how to stop? – Herm Lamberink (Netherlands)
  • Seminar with cases – discussion
  • Summary and outcome of the learning objectives – Cecilie Johannessen Landmark (Norway)


Half-day Teaching Course: No response to first ASMs. What next?

Co-chairs: Torbjörn Tomson (Sweden) & Jacqueline French (USA)

This session will address the options after the first and second failed ASM.

  • Resistant or pseudo-resistant: things to consider before changing anti-seizure medicine (ASM) – Torbjörn Tomson (Sweden)
  • Failure of first ASM: is every drug the same? – Jacqueline French (USA)
  • Debate: Switch or add after first failed ASM: For switch – Jacqueline French (USA); For add –  Anthony Marson (United Kingdom)
  • 2ndASM failure: which ASM to add and how? –  Anthony Marson (United Kingdom)
  • Non- pharmacologic alternatives to a 3rd ASM – Andrea Rossetti (Switzerland)


Half-day Teaching Course: Genetic testing: whom, when and what to test

Chair: Guido Rubboli (Denmark)

This session will give an overview on the clinical use of genetic testing in patients with epilepsy.

  • Genetics of the epilepsies: state-of-the art in 2020 – Renzo Guerrini (Italy)
  • The impact of genetics in our understanding of developmental epileptic encephalopathies – Rima Nabbout (France)
  • A rational approach to genetic testing in epilepsy patients – Reetta Kälviäinen (Finland)
  • Yields of genetic testing in clinical practice – Guido Rubboli (Denmark)
  • Interactive discussion including case studies with the participants


Half-day Teaching Course: Epilepsy surgery: learn from cases!

Co-chairs: Ivan Rektor (Czech Republic) & Çiğdem Özkara (Turkey)

This session will describe the challenges of presurgical evaluation, using case-based learning.

  • Introduction to epilepsy surgery
  • Frontal lobe epilepsy – Ivan Rektor (Czech Republic)
  • Temporal lobe and temporal plus epilepsy – Philippe Kahane (France)
  • Posterior cortex epilepsy – Çiğdem Özkara (Turkey)
  • Cognitive risks and trade-offs – Kristina Malmgren (Sweden)


Half-day Teaching Course: Status epilepticus

Co-chairs: Eugen Trinka (Austria) & Simon Shorvon (United Kingdom)

This session will provide an overview of challenges diagnosing classifying and treating a highly dynamic condition, using case-based learning.

  • Definition, classification, and epidemiology of status epilepticus –Eugen Trinka (Austria)
  • Causes of status epilepticus – Simon Shorvon (United Kingdom)
  • Management early and established status epilepticus – Julia Höfler (Austria)
  • Management of refractory status epilepticus – Monica Ferlisi (Italy)


Teaching Session: VIREPA Basic & Advanced EEG

  • Bogdan Lorber (Slovenia)
  • Antonio Valentin (United Kingdom)


Teaching Session: VIREPA Paediatric EEG & Sleep

  • Monika Eisermann (France)
  • Lino Nobili (Italy)


Teaching Session: Advanced EEG: source imaging – part 1 (Theory)

  • Sandor Beniczky (Denmark)
  • Pierre Megevand (Switzerland)
  • Stefan Rampp (Germany)


Teaching Session: Advanced EEG: source imaging – part 2 (Hands-on)

  • Sandor Beniczky (Denmark)
  • Pierre Megevand (Switzerland)
  • Stefan Rampp (Germany)


Teaching Session: Video session – paediatric

  • Ronit Pressler (United Kingdom)
  • Nicola Specchio (Italy)
  • Alexis Arzimanoglou (France)


Teaching Session: Video session – adult

  • Guido Rubboli (Denmark)
  • Matthew Walker (United Kingdom)
  • Laura Tassi (Italy)


Teaching Session: Immunity, inflammation and epilepsy

Chair:  Christian Bien (Germany)

  • The immunology underlying of autoimmune epilepsies – Sarosh Irani (United Kingdom)
  • Epileptogenic mechanisms of human autoantibodies – Christian Geis (Germany)
  • Management of patients with suspected autoimmune epilepsy – Christian Bien (Germany)
  • Autoimmune epilepsy in paediatric patients – Sukhvir Wright (United Kingdom)


Teaching Session: Epileptic encephalopathies

  • Federico Vigevano (Italy)
  • Alexis Arzimanoglou (France)
  • J Helen Cross (United Kingdom)

ILAE Wikipedia Project Workshop

The ILAE Wikipedia Project is hosting its second workshop during the 14th European Congress on Epileptology. This exciting initiative is dedicated to improving the health content related to epilepsy on Wikipedia. Join this educational and practical opportunity and help existing content or create new information with experts. Places on this popular workshop are limited and all are welcome to apply.

If you are interested in taking part in this workshop send your CV and a short text explaining your interest to

Deadline: 28 February 2020




ILAE Nursing Task Force

The ILAE Nursing Task Force is hosting its first ever meeting during the 14th European Congress on Epileptology. This inaugural meeting will focus on topics such as leadership, knowledge of epilepsy, how to deal with seizures correctly amongst other talks. This exciting meeting takes place on Tuesday 7 July at 08.00 to 16.30. While priority will be given to those in the nursing profession, other healthcare professions are also welcome. Registration for this meeting is free but is limited to this meeting only.

Places are limited, so early registration is recommended. Send notification of your interest to:

The full programme can be accessed here.

Deadline: 30 April 2020

The ILAE Young Epilepsy Section (ILAE-YES) will host 3 brainstorming sessions in the Exhibition Hall during the coffee breaks on Monday, Tuesday and Wednesday. Details of the sessions are below.

ILAE-YES Brainstorming Session: What is a seizure?

  • Keynote speaker – Marco de Curtis (Italy)

ILAE-YES Brainstorming Session: Epilepsy and climate change

  • Keynote speaker – Sanjay Sisodiya (United Kingdom)

ILAE-YES Brainstorming Session: Towards less invasive approaches in epilepsy surgery

  • Keynote speaker – Laura Tassi (Italy)